RAFAEL HOLDINGS, INC. Increase (Decrease) in Due from Related Parties
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Due from Related Parties of $40.00 thousand for the 9-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. increase (decrease) in due from related parties for the quarter ending 2023-04-30 was -$29.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in due from related parties for the quarter ending 2023-01-31 was $44.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in due from related parties for the quarter ending 2022-10-31 was $25.00K, a 70.24% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in due from related parties for the quarter ending 2022-04-30 was -$12.00K, a 110.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. increase (decrease) in due from related parties for fiscal 2021 was $482.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in due from related parties for fiscal 2020 was -$162.00K, a 157.86% decline from fiscal 2019.
- RAFAEL HOLDINGS, INC. increase (decrease) in due from related parties for fiscal 2019 was $280.00K.
| Period end | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 9 month | Increase (Decrease) in Due from Related Parties 12 month |
|---|---|---|---|---|
| 2023-04-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $15.00K derived: sum of 2 quarters · filed 2023-06-13 | $40.00K 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $69.00K 10-Q · filed 2023-03-14 | ||
| 2022-10-31 | $25.00K 10-Q · filed 2022-12-13 | |||
| 2022-04-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | -$17.00K derived: sum of 2 quarters · filed 2023-06-13 | $67.00K 10-Q · filed 2023-06-13 | $187.00K derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-01-31 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $79.00K 10-Q · filed 2023-03-14 | $199.00K derived: sum of 3 quarters · filed 2023-03-14 | $319.00K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-10-31 | $84.00K 10-Q · filed 2022-12-13 | $204.00K derived: sum of 2 quarters · filed 2022-12-13 | $324.00K derived: sum of 3 quarters · filed 2022-12-13 | |
| 2021-07-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $240.00K derived: sum of 2 quarters · filed 2022-10-31 | $482.00K 10-K · filed 2022-10-31 | |
| 2021-04-30 | $120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | $362.00K 10-Q · filed 2021-06-14 | ||
| 2021-01-31 | $242.00K 10-Q · filed 2021-03-17 | |||
| 2020-07-31 | -$269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | -$36.00K derived: sum of 2 quarters · filed 2021-10-18 | -$2.00K derived: sum of 3 quarters · filed 2021-10-18 | -$162.00K 10-K · filed 2021-10-18 |
| 2020-04-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $267.00K derived: sum of 2 quarters · filed 2020-06-09 | $107.00K 10-Q · filed 2020-06-09 | -$86.00K derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-01-31 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-03-05 | -$126.00K 10-Q · filed 2020-03-05 | -$319.00K derived: sum of 3 quarters · filed 2020-10-29 | $742.00K derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-10-31 | -$160.00K 10-Q · filed 2019-12-09 | -$353.00K derived: sum of 2 quarters · filed 2020-10-29 | $708.00K derived: sum of 3 quarters · filed 2020-10-29 | |
| 2019-07-31 | -$193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $868.00K derived: sum of 2 quarters · filed 2020-10-29 | $280.00K 10-K · filed 2020-10-29 | |
| 2019-04-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $473.00K 10-Q · filed 2020-06-09 | ||
| 2019-01-31 | -$588.00K 10-Q · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |